GSK plc
GLAXFOTCHealthcare● Active
$24.66
+$0.72(+3.01%)
Market Cap$98.9B
P/E Ratio—
52W High$31.48
52W Low$17.15
GSK plc (GLAXF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GLAXF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $32.66B | $31.38B | $30.33B | $29.32B | $34.11B |
| Cost of Revenue | $8.97B | $9.05B | $8.56B | $9.55B | $11.60B |
| Gross Profit | $23.69B | $22.33B | $21.76B | $19.77B | $22.51B |
| Gross Margin %(computed) | 72.54% | 71.16% | 71.76% | 67.42% | 65.99% |
| Operating Expenses | |||||
| R&D Expenses | $7.51B | $6.40B | $6.22B | $5.49B | $5.28B |
| G&A Expenses | $0.00B | $11.02B | $9.38B | $8.37B | $10.97B |
| Total Operating Expenses | $16.53B | $18.31B | $15.02B | $13.34B | $16.31B |
| Operating Income | $7.17B | $4.02B | $6.75B | $6.43B | $4.36B |
| Operating Margin %(computed) | 21.95% | 12.82% | 22.24% | 21.94% | 12.77% |
| Interest Income | $0.17B | $0.06B | $0.06B | $0.06B | $0.03B |
| Interest Expense | $0.70B | $0.64B | $0.78B | $0.84B | $0.78B |
| Income Before Tax | $7.40B | $3.48B | $6.06B | $5.63B | $3.86B |
| Income Tax Expense | $1.11B | $0.53B | $0.76B | $0.71B | $0.35B |
| Net Income | $5.72B | $2.58B | $4.93B | $14.96B | $4.38B |
| Net Margin %(computed) | 17.50% | 8.21% | 16.25% | 51.00% | 12.85% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.41 | $0.63 | $1.22 | $3.71 | $1.37 |
| Wtd Avg Shares | 4.05B | 4.08B | 4.11B | 4.03B | 3.20B |
| EBITDA | $11.88B | $6.67B | $9.08B | $8.60B | $6.49B |
| EBITDA Margin %(computed) | 36.38% | 21.25% | 29.95% | 29.33% | 19.01% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · GBP · B
Explore more GSK plc data
About GSK plc (GLAXF) Income Statement
GSK plc (GLAXF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GLAXF reported revenue of $32.66B, gross profit of $23.69B (gross margin 72.54%), and net income of $5.72B — a net profit margin of 17.50%.
Frequently asked questions
GLAXF · 4 questionsGSK plc (GLAXF) reported revenue of $32.66B for 2025, up 4.1% year-over-year.
GLAXF revenueGLAXF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08